116 related articles for article (PubMed ID: 7887850)
1. Retinopathy in galactosemic dogs continues to progress after cessation of galactosemia.
Engerman RL; Kern TS
Arch Ophthalmol; 1995 Mar; 113(3):355-8. PubMed ID: 7887850
[TBL] [Abstract][Full Text] [Related]
2. Comparison of retinal lesions in alloxan-diabetic rats and galactose-fed rats.
Kern TS; Engerman RL
Curr Eye Res; 1994 Dec; 13(12):863-7. PubMed ID: 7720392
[TBL] [Abstract][Full Text] [Related]
3. Effect of galactose diet removal on the progression of retinal vessel changes in galactose-fed dogs.
Kador PF; Takahashi Y; Akagi Y; Neuenschwander H; Greentree W; Lackner P; Blessing K; Wyman M
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1916-21. PubMed ID: 12036999
[TBL] [Abstract][Full Text] [Related]
4. Aqueous flow in galactose-fed dogs.
Toris CB; Lane JT; Akagi Y; Blessing KA; Kador PF
Exp Eye Res; 2006 Oct; 83(4):865-70. PubMed ID: 16797006
[TBL] [Abstract][Full Text] [Related]
5. Nerve conduction velocity in dogs is reduced by diabetes and not by galactosemia.
Engerman RL; Kern TS; Larson ME
Metabolism; 1990 Jun; 39(6):638-40. PubMed ID: 2352480
[TBL] [Abstract][Full Text] [Related]
6. Galactose-induced retinal microangiopathy in rats.
Kern TS; Engerman RL
Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):490-6. PubMed ID: 7843917
[TBL] [Abstract][Full Text] [Related]
7. Hyperglycemia as a cause of diabetic retinopathy.
Engerman RL; Kern TS
Metabolism; 1986 Apr; 35(4 Suppl 1):20-3. PubMed ID: 3083205
[TBL] [Abstract][Full Text] [Related]
8. An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia.
Frank RN; Amin R; Kennedy A; Hohman TC
Arch Ophthalmol; 1997 Aug; 115(8):1036-47. PubMed ID: 9258227
[TBL] [Abstract][Full Text] [Related]
9. Retinal vessel changes in galactose-fed dogs.
Kobayashi T; Kubo E; Takahashi Y; Kasahara T; Yonezawa H; Akagi Y
Arch Ophthalmol; 1998 Jun; 116(6):785-9. PubMed ID: 9639449
[TBL] [Abstract][Full Text] [Related]
10. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.
Kern TS; Tang J; Mizutani M; Kowluru RA; Nagaraj RH; Romeo G; Podesta F; Lorenzi M
Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3972-8. PubMed ID: 11053301
[TBL] [Abstract][Full Text] [Related]
11. Experimental galactosemia produces diabetic-like retinopathy.
Engerman RL; Kern TS
Diabetes; 1984 Jan; 33(1):97-100. PubMed ID: 6360771
[TBL] [Abstract][Full Text] [Related]
12. Diabeteslike proliferative retinal changes in galactose-fed dogs.
Kador PF; Takahashi Y; Wyman M; Ferris F
Arch Ophthalmol; 1995 Mar; 113(3):352-4. PubMed ID: 7887849
[TBL] [Abstract][Full Text] [Related]
13. Diabetic-like retinopathy: early and late intervention therapies in galactose-fed rats.
Robison WG; Jacot JL; Glover JP; Basso MD; Hohman TC
Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1933-41. PubMed ID: 9727416
[TBL] [Abstract][Full Text] [Related]
14. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy.
Kowluru RA; Tang J; Kern TS
Diabetes; 2001 Aug; 50(8):1938-42. PubMed ID: 11473058
[TBL] [Abstract][Full Text] [Related]
15. Effects of aldose reductase inhibitors and galactose withdrawal on fluorescein angiographic lesions in galactose-fed dogs.
Cusick M; Chew EY; Ferris F; Cox TA; Chan CC; Kador PF
Arch Ophthalmol; 2003 Dec; 121(12):1745-51. PubMed ID: 14662595
[TBL] [Abstract][Full Text] [Related]
16. The galactosemic dog. A valid model for both early and late stages of diabetic retinopathy.
Frank RN
Arch Ophthalmol; 1995 Mar; 113(3):275-6. PubMed ID: 7887838
[No Abstract] [Full Text] [Related]
17. Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs.
Engerman RL; Kern TS
Diabetes; 1993 Jun; 42(6):820-5. PubMed ID: 8495805
[TBL] [Abstract][Full Text] [Related]
18. Termination of experimental galactosemia in rats, and progression of retinal metabolic abnormalities.
Kowluru RA; Koppolu P
Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3287-91. PubMed ID: 12356836
[TBL] [Abstract][Full Text] [Related]
19. Renal hemodynamics in experimentally galactosemic dogs and diabetic dogs.
Kern TS; Engerman RL
Metabolism; 1991 May; 40(5):450-4. PubMed ID: 1902544
[TBL] [Abstract][Full Text] [Related]
20. Diabetic-like retinopathy ameliorated with the aldose reductase inhibitor WAY-121,509.
Robinson WG; Laver NM; Jacot JL; Glover JP; Basso MD; Blouin P; Hohman TC
Invest Ophthalmol Vis Sci; 1996 May; 37(6):1149-56. PubMed ID: 8631629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
